This meeting will examine the findings and policy and implementation implications arising from the FORESFA Collaboration, the VIE Consortium, and the DAFODIL Dashboard Project, with a focus on new evidence and innovative approaches to identifying the sources and trade routes of falsified medicines and vaccines, assessing the impact of substandard and falsified antimicrobials on patient outcomes and antimicrobial resistance, advancing screening techniques within supply chains, and developing systems to collate and evaluate the performance of screening technologies.